Soolantra Cream
Product Images NDC 0299-3823

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Soolantra (NDC 0299-3823). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Galderma Laboratories, L.p., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Soolantra_30g_carton_p52447-1 (P52477 1 Etui Soolantra 1 Cream 30g Usa (051209))

Soolantra (ivermectin) cream, 1% topical cream in a 30 g package, marketed by Galderma Laboratories, L.P. The label shows the product name, active ingredient ivermectin, strength 1%, and directions indicating Rx only, topical use, and to keep out of reach of children. It includes the Galderma logo, lot number, expiration date, barcode, and manufacturing information.*

FDA Label Image

Ivermectin-chem-struct (Ivermectin Chem Struct)

Chemical structure of ivermectin, the active ingredient in SOOLANTRA 10 mg/g topical cream by Galderma Laboratories, L.P. The image depicts the detailed molecular diagram of ivermectin including various rings and functional groups.*

FDA Label Image

Ivermectin-fig-1-fig-2 (Ivermectin Fig 1 Fig 2)

Two line graphs comparing the IGA Success Rate (%) over time (Baseline to Week 12) between SOOLANTRA Cream and Vehicle Cream. Each graph represents a different study (Study 1 and Study 2), showing SOOLANTRA Cream to have a higher success rate increase compared to Vehicle Cream across visits.*

FDA Label Image

Ivermectin-fig-3-fig-4 (Ivermectin Fig 3 Fig 4)

Two line graphs labeled Study 1 and Study 2 showing the mean change in inflammatory lesions over time for SOOLANTRA Cream versus Vehicle Cream. The x-axis represents visit weeks (Baseline, Week 2, Week 4, Week 8, Week 12), and the y-axis shows mean change in inflammatory lesions. SOOLANTRA Cream demonstrates higher mean lesion reduction compared to Vehicle Cream in both studies, with data points indicated by filled circles for SOOLANTRA and open triangles for Vehicle.*

FDA Label Image

Ivermectin-fig-a-fig-b (Ivermectin Fig A Fig B)

Instructional illustrations showing how to open a tube cap. Figure A depicts a hand positioning the cap for opening, and Figure B shows the removal of the cap from the tube. The drawings focus on the manual steps for accessing the tube contents.*

FDA Label Image

Ivermectin-fig-c (Ivermectin Fig C)

An instructional illustration showing a hand applying a strip of cream to the index finger. The image appears to be part of a step-by-step guide for topical cream application, labeled as Figure C.*

FDA Label Image

Ivermectin-fig-d (Ivermectin Fig D)

An instructional illustration showing a hand opening a tube by twisting its cap. The image demonstrates how to prepare the topical cream tube for use, likely part of a user guide for SOOLANTRA cream.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.